Abstract
Cutaneous angiosarcoma (AS) is a rare, aggressive malignancy with a poor prognosis. It usually arises on the scalp or face and is locally advanced at presentation. Patients are most often white, male, and elderly. A subset of patients present with multifocal disease and/or positive regional nodes. Another group of patients who may present with AS are patients treated with a partial mastectomy and radiotherapy (RT) for breast cancer. Although the optimal treatment is surgery followed by wide-field RT, the disease is sometimes so extensive at diagnosis that it is not completely resectable. Even after optimal local-regional treatment, there is a relatively high likelihood of a local recurrence at the margins of the RT fields. The probability of hematogenous dissemination is relatively high. Limited data suggest that chemotherapy may be useful for palliation with progression-free survival rates ranging from 1 to 5 months. Depending on primary site, the 5-year local-regional control rates are approximately 40–50 %, the 5-year distant metastasis-free survival rates range from 20 to 40 %, and the 5-year survival rates range from 10 to 30 %. AS arising on the scalp has the worst prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hodgkinson DJ, Soule EH, Woods JE. Cutaneous angiosarcoma of the head and neck. Cancer. 1979;44(3):1106–13.
Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59(5):1046–57.
Sasaki R, Soejima T, Kishi K, Imajo Y, Hirota S, Kamikonya N, et al. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys. 2002;52(4):1032–40.
Ward JR, Feigenberg SJ, Mendenhall NP, Marcus Jr RB, Mendenhall WM. Radiation therapy for angiosarcoma. Head Neck. 2003;25(10):873–8.
Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer. 2003;98(8):1716–26.
Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996;77(11):2400–6.
Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11(3):241–7.
Palta M, Morris CG, Grobmyer SR, Copeland III EM, Mendenhall NP. Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer. 2010;116(8):1872–8.
Schmid H, Zietz C. Human herpesvirus 8 and angiosarcoma: analysis of 40 cases and review of the literature. Pathology. 2005;37(4):284–7.
Zietz C, Rumpler U, Sturzl M, Lohrs U. Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack. Am J Pathol. 2001;159(3):963–70.
Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients. Br J Dermatol. 2004;150(1):160–1.
Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Observations on angiopoietin 2 in patients with angiosarcoma. Br J Dermatol. 2004;150(5):1028–9.
Isoda H, Imai M, Inagawa S, Miura K, Sakahara H. Magnetic resonance imaging findings of angiosarcoma of the scalp. J Comput Assist Tomogr. 2005;29(6):858–62.
Klijanienko J, Caillaud JM, Lagace R, Vielh P. Cytohistologic correlations in angiosarcoma including classic and epithelioid variants: Institut Curie’s experience. Diagn Cytopathol. 2003;29(3):140–5.
American Joint Committee on Cancer, editor. Soft tissue sarcoma. AJCC Cancer Staging Manual. New York, NY: Springer; 2002. p. 193–200.
Scott MT, Portnow LH, Morris CG, Marcus RB, Jr., Mendenhall NP, Mendenhall WM, et al. Radiation therapy for angiosarcoma: the 35-year University of Florida experience. Am J Clin Oncol. 2012;36(2):174–80.
Isogai R, Kawada A, Aragane Y, Tezuka T. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol. 2004;31(4):335–41.
Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. J Eur Acad Dermatol Venereol. 2005;19(3):357–9.
Wollina U, Fuller J, Graefe T, Kaatz M, Lopatta E. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol. 2001;127(6):396–9.
Bong AB, Bonnekoh B, Schon MP, Gollnick H. Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa. J Am Acad Dermatol. 2005;52(2 Suppl 1):20–3.
Eiling S, Lischner S, Busch JO, Rothaupt D, Christophers E, Hauschild A. Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin. Br J Dermatol. 2002;147(1):150–3.
Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104(2):361–6.
Yamada M, Hatta N, Mizuno M, Oishi N, Takehara K. Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head. Br J Dermatol. 2005;152(4):811–2.
Morrison WH, Byers RM, Garden AS, Evans HL, Ang KK, Peters LJ. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer. 1995;76(2):319–27.
Tung SS, Shiu AS, Starkschall G, Morrison WH, Hogstrom KR. Dosimetric evaluation of total scalp irradiation using a lateral electron-photon technique. Int J Radiat Oncol Biol Phys. 1993;27(1):153–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mendenhall, W.M., Mendenhall, N.P. (2013). Radiotherapy for Cutaneous Angiosarcoma. In: Cognetta Jr., A., Mendenhall, W. (eds) Radiation Therapy for Skin Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6986-5_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6986-5_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6985-8
Online ISBN: 978-1-4614-6986-5
eBook Packages: MedicineMedicine (R0)